BIO opposes use of same names for biosimilars, biologics

10/30/2013 | Drug Store News

Biosimilar drugs should not have the same names as branded biologics because they are made from different cell lines, BIO said. Biosimilars and biologics are not identical. "Use of the same nonproprietary name suggests something that is not true for biosimilars -- that they are the same as the innovator drugs they reference," according to a recent statement from BIO.

View Full Article in:

Drug Store News

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Site Quality Management
Minneapolis, MN
In house Compliance Officer
Pompano Beach, FL
Clinical Project Manager
Abiomed, Inc.
Danvers, MA
Sr. Manager, Regulatory Affairs - International
Integra LifeSciences
Plainsboro, NJ
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC